Bank of America Passes Federal Reserve Stress Test; Micron Technology Unveils New M550 SSD Drive

Follow this company

Companies Mentioned

03/24/2014 [ACCESSWIRE]

Bank of America Corporation (NYSE: BAC) – For an in-depth report on Bank of America Corporation follow:                     

BAC shares closed down a modest 2.01% on Friday with about 156 million shares traded. The stock hit a new 52-week high of $18.03 during intra-day trading before retracing. The Federal Reserve announced the results of the stress tests and 29 out of 30 participants passed the test. Bank of America (BAC) was also one of the participants and the bank's capital ratio was enough to satisfy the demands of the test.

Micron Technology Inc. (NASDAQ: MU) - For an in-depth report on Micron Technology Inc. follow:

Shares of Micron Technology shares closed down 1.46% on about 32 million shares traded. The stock was one of the most active stocks on the NASDAQ. Last week the company unveiled its new solid state drive (SSD), M550. The M550 SSD enables quick access to files and is more power efficient resulting in longer battery life. Moreover, the new SSD is equipped with hardware encryption facility coupled with data protection and recovery features. M550 will be made available via Micron brand to the original equipment manufacturers and under the Crucial brand to customers and system builders.

United Treatment Centers, Inc. (OTC: UTRM) - For an in-depth report on United Treatment Centers, Inc. follow:

UTRM closed up 76.74% this past Friday on about 775 million shares traded. The stock was one of the biggest gainers in the OTC marketplace. Last week the company’s newly appointed CEO and President, announced that the company has verified with the transfer agent that the cancellation of the 3,000,000,000 shares of common stock announced on February 7, 2014 has been completed.

Terra Tech Corp. (OTC: TRTC) - For an in-depth report on Terra Tech Corp. follow:

Shares of TRTC closed down roughly 10% this past Friday on nearly 9.5 million shares traded. The stock was one of the biggest decliners in the OTC market. Last week the leading developer of nutritional supplements, today announced the appointment of Dr. Michelle Sexton to its Scientific/Medical Advisory Board for guiding the formulation of the proprietary line of cannabidiol (CBD)-based nutritional supplements it is developing in partnership with Terra Tech Corp (TRTC).  The two companies announced the formation of the Scientific/Medical Advisory Board on March 5, 2014.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name